Dashboard
Manage Tickers

MGROVanEck Morningstar Wide Moa...


$ 28.51 $ -0.05 (-0.17 %)    

Friday, 19-Jul-2024 14:53:36 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 30.4065
$ 29.40 x 100
-- x --
-- - --
$ 27.55 - $ 32.00
2
na
na
$ 0.82
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

agilent-navigates-market-challenges-q3-exceeds-expectations-as-strategic-investments-pay-off
Agilent Navigates Market Challenges: Q3 Ex...
08/22/2024 13:44:43

Agilent Technologies reports Q3 results with revenue of $1.58B, surpassing street view. Q4 revenue forecasted at $1.641B-$1.691...

weak-china-sales-hit-estee-lauders-q4-ceo-to-retire
Weak China Sales Hit Estee Lauder's Q4, CE...
08/19/2024 12:40:39

Estee Lauder reported 7% sales growth, with Skin Care leading the way. Adjusted EPS beat estimates. CEO to retire, company expe...

why-professional-services-company-equifax-shares-are-surging-today
Why Professional Services Company Equifax ...
07/18/2024 16:18:00

Equifax shares surged after beating revenue expectations in Q2 FY24 with growth in Workforce Solutions and EPS above estimates.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION